https://www.selleckchem.com/products/ggti-298.html
Cerebrospinal fluid α-synuclein (CSF α-syn) represents a possible biomarker in Parkinson's disease (PD) diagnosis. CSF blood contamination can introduce a bias in α-syn measurement. To date, CSF samples with a red blood cells (RBC) count 50 RBC×10 /L or haemoglobin (Hb) concentration 200μg/L are excluded from biomarker studies. However, investigations for defining reliable cut-off values are missing. We evaluated the effect of blood contamination on CSF α-syn measurement by a systematic approach in a cohort of 42 patients with